vimarsana.com
Home
Live Updates
Ibrutinib Plus R-CHOP Cost-Effective for Young Patients With
Ibrutinib Plus R-CHOP Cost-Effective for Young Patients With
Ibrutinib Plus R-CHOP Cost-Effective for Young Patients With ABC-DLBCL
Although ibrutinib adds to the cost of treatment, its benefits over the long term justify the cost, investigators found.
Related Keywords
Phoenix ,
Arizona ,
United States ,
,
Image Credit ,
Ibrutinib ,
R Chop ,
Abc Dlbcl ,
Btk Inhibitor ,
I Rchop ,